The prevention of Rh haemolytic disease of the fetus and newborn — general background
Open Access
- 1 November 1998
- journal article
- review article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 105 (s18) , 7-10
- https://doi.org/10.1111/j.1471-0528.1998.tb10285.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Failures of Intravenous Rh Immune Globulin Prophylaxis: An Analysis of the Reasons for Such FailuresTransfusion Medicine Reviews, 1987
- Failure of Passively Administered Anti-Rh to Prevent Secondary Rh ResponsesVox Sanguinis, 1985
- THE YORKSHIRE ANTENATAL ANTI-D IMMUNOGLOBULIN TRIAL IN PRIMIGRAVIDAEThe Lancet, 1983
- Studies on Rh ProphylaxisTransfusion, 1971
- Anti-D Concentration in Mother and Child in Haemolytic Disease of the NewbornVox Sanguinis, 1971
- Results of Clinical Trials of RhoGAM* in WomenTransfusion, 1968
- Prevention of Rh-haemolytic disease: results of the clinical trial. A combined study from centres in England and Baltimore.BMJ, 1966
- Rh Factor: Prevention of Isoimmunization and Clinical Trial on MothersScience, 1966
- Successful Prevention of Experimental Rh Sensitization in Man with an Anti‐Rh Gamma2‐Globulin Antibody Preparation: A Preliminary ReportTransfusion, 1964
- Experimental Studies on the Prevention of Rh Haemolytic DiseaseBMJ, 1961